Key facts
- It has raised $500K; the latest was Early Stage VC in Nov 2025.
- Notable investors include Y Combinator, Emergent Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for CombineHealth
- ·The full record, as it builds
Funding rounds
No funding rounds for CombineHealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CombineHealth
Developer of an AI-powered revenue cycle management platform intended to assist healthcare organizations with claims processing and payment optimization. The company uses generative and agentic AI models, claims-flow automation, denial-detection analytics, and customizable rule engines, enabling hospitals and clinics to improve coding accuracy, reduce accounts receivable, and enhance payment consistency across specialties.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2022
- Employees
- 16
- Website
- combinehealth.ai/
- Ownership
- Privately Held (backing)
CombineHealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CombineHealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CombineHealth in its N-PORT filings yet. We sweep new filings monthly.